中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

Clinical features of diabetic patients with bacterial liver abscess and different levels of glycosylated hemoglobin

DOI: 10.3969/j.issn.1001-5256.2019.11.029
  • Received Date: 2019-06-11
  • Published Date: 2019-11-20
  • Objective To investigate the clinical features of diabetic patients with bacterial liver abscess and different levels of glycosylated hemoglobin( Hb Alc). Methods A total of 118 adult diabetic patients with bacterial liver abscess who were admitted to our hospital from December 2014 to December 2018 were enrolled,and according to the level of Hb Alc,they were divided into well-controlled group with 32 patients,fairly-controlled group with 31 patients,and poorly-controlled group with 55 patients. The three groups were compared in terms of general data,clinical manifestations,laboratory results,complications,and pathogen test results. A one-way analysis of variance was used for comparison of continuous data between multiple groups,and the least significant difference t-test was used for further comparison between two groups; the chi-square test or the Fisher's exact test was used for comparison of categorical data between groups. Results There were significant differences in mean age and length of hospital stay between the three groups( F = 2. 933 and 3. 310,both P < 0. 05). Compared with the other two groups,the poorly-controlled group had a significantly younger mean age of onset( P = 0. 016) and a significantly longer length of hospital stay( P = 0. 044). Hypertension was the most common underlying disease in diabetic patients with liver abscess,followed by biliary tract diseases and cerebral infarction,and there was a significant difference in cerebral infarction between the three groups( χ2= 6. 135,P =0. 037). Compared with the well-controlled group,the poorly-controlled group had significantly fewer and less typical signs of abdominal tenderness( χ2= 6. 178,P = 0. 046),and compared with the other two groups,the poorly-controlled group tended to have a significant increase in C-reactive protein( χ2= 5. 985,P = 0. 049) and were more likely to develop sepsis( χ2= 6. 247,P = 0. 044). Conclusion For diabetic patients with bacterial liver abscess,the patients with a poorly controlled Hb Alc level often have a young age of onset,a long length of hospital stay,and atypical clinical signs and are likely to develop sepsis,which may lead to insufficient attention in clinical practice,delay diagnosis and treatment,and even endanger life,and therefore,such patients should be taken seriously in clinical practice.

     

  • [1] AKHONDI H,SABIH DE. Liver abscess[M]. Treasure Island(FL):Stat Pearls Publishing Stat Pearls Publishing LLC,2019.
    [2] LI W,CHEN H,WU S,et al. A comparison of pyogenic liver abscess in patients with or without diabetes:A retrospective study of246 cases[J]. BMC Gastroenterol,2018,18(1):144.
    [3] WANG HH. The association of haemoglobin A(1)C levels with the clinical and CT characteristics of Klebsiella pneumoniae liver abscesses in patients with diabetes mellitus[J]. Eur Radiol,2014,24(5):980-989.
    [4] WHO. New diagnostic criteria and typing system for diabetes[J]. Chin J Diabetes,2000,8(1):5-6.(in Chinese)WHO.关于糖尿病的新诊断标准与分型[J].中国糖尿病杂志,2000,8(1):5-6.
    [5] CHEN J. Cryptogenic and non-cryptogenic liver abscess:A retrospective analysis of 178 cases revealed distinct characteristics[J]. Int Med Res,2018,46(9):3824-3836.
    [6] KUBOVY J,KARIM S,DING S,et al. Pyogenic liver abscess:Incidence,causality,management and clinical outcomes in a New Zealand cohort[J]. N Z Med J,2019,132(1492):30-35.
    [7] WANG WJ,TAO Z,WU HL,et al. Etiology and clinical manifestations of bacterial liver abscess:A study of 102 cases[J]. Medicine(Baltimore),2018,97(38):e12326.
    [8] MCEWAN P,FOOS V,LAMOTTE M,et al. The impact of baseline Hba1c and Hba1c trajectories on time to therapy escalation in type 2 diabetes mellitus[J]. Value Health,2015,18(7):a698.
    [9] WALRAVEN L. Distinct HbA1c trajectories in a type 2 diabetes cohort[J]. Acta Diabetol,2015,52(2):267-275.
    [10] Chinese Society of Diabetes,Chinese Medical Association.Guidelines for the prevention and treatment of type 2 diabetes in China(version 2017)[J]. Chin J Diabetes,2018,10(1):4-67.(in Chinese)中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67.
    [11] QIU YP,ZHANG YC,XU YH. Study on the influence of changes in blood levels of HbAlc on hypertension and coronary heart disease in patients with diabetes mellitus[J]. J Clin Exp Med,2018,17(2):166-169.(in Chinese)邱永平,张运超,徐悦和.糖尿病患者糖化血红蛋白水平变化对高血压及冠心病的临床影响分析[J].临床和实验医学杂志,2018,17(2):166-169.
    [12] KO MC. A cohort study of age and sex specific risk of pyogenic liver abscess incidence in patients with type 2 diabetes mellitus[J]. Medicine(Baltimore),2019,98(17):e15366.
    [13] LAI YR. HbA1C variability is strongly associated with the severity of peripheral neuropathy in patients with type 2 diabetes[J]. Front Neurosci,2019,13:90.
    [14] ZHANG J. Comparison of clinical characteristics and outcomes of pyogenic liver abscess patients <65 years of age versus>/=65 years of age[J]. BMC Infect Dis,2019,19(1):233.
    [15] LEE CR. Antimicrobial resistance of hypervirulent klebsiella pneumoniae:Epidemiology, hypervirulence-associated determinants,and resistance mechanisms[J]. Front Cell Infect Microbiol,2017,7:483.
    [16] SHANKAR C,VEERARAGHAVAN B. Whole genome analysis of hypervirulent Klebsiella pneumoniae isolates from community and hospital acquired bloodstream infection[J]. BMC Microbiol,2018,18(1):6.
    [17] JUN JB. Klebsiella pneumoniae liver abscess[J]. Infect Chemother,2018,50(3):210-218.
    [18] CHEN F,ZHANG YT,QIAO HJ,et al. Clinical features of Klebsiella pneumoniae liver abscess[J]. J Clin Hepatol,2016,32(4):764-768.(in Chinese)陈帆,张艳亭,乔慧捷,等.肺炎克雷伯菌肝脓肿的临床特征分析[J]临床肝胆病杂志,2016,32(4):764-768.
    [19] HUANG Y. Research advances in diagnosis and treatment of bacterial liver abscess[J]. J Clin Hepatol,2018,34(3):641-644.(in Chinese)黄洋.细菌性肝脓肿的诊治进展[J].临床肝胆病杂志,2018,34(3):641-644.
  • Relative Articles

    [1]Jinqiu YANG, Wenxia ZHAO, Cheng ZHOU, Tong LIU. Risk factors for the development of advanced liver fibrosis in nonalcoholic fatty liver disease and establishment of a nomogram model[J]. Journal of Clinical Hepatology, 2024, 40(8): 1579-1584. doi: 10.12449/JCH240812
    [2]Jing KUANG, Shuangqin TENG, Tongtong SHEN, Yiran YAN, Wei WANG, Chuan SHEN, Caiyan ZHAO. Risk factors for portopulmonary hypertension in liver cirrhosis and construction of a predictive model[J]. Journal of Clinical Hepatology, 2024, 40(9): 1802-1806. doi: 10.12449/JCH240914
    [3]Decai KONG, Xiaojing ZHANG, Yangguang YUN, Haoyu DUAN, Junfeng YE. Risk factors for biliary stricture and prognosis after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2024, 40(11): 2253-2259. doi: 10.12449/JCH241119
    [4]Mingqiang ZHU, Dashuai YANG, Junpeng PEI, Xiangyun XIONG, Yang SU, Youming DING. Analysis of influencing factors on biliary complications after orthotopic liver transplantation[J]. Journal of Clinical Hepatology, 2023, 39(7): 1627-1632. doi: 10.3969/j.issn.1001-5256.2023.07.017
    [5]Sufang LU, Rui HUANG, Hongli ZHAO, Dandan WANG, Yuzhen DING, Hong ZHOU. Value of a risk assessment model in predicting venous thromboembolism in patients with liver failure after artificial liver support therapy[J]. Journal of Clinical Hepatology, 2023, 39(3): 613-619. doi: 10.3969/j.issn.1001-5256.2023.03.019
    [6]Bingbing ZHU, Jinxiang YANG, Qun ZHANG, Fangyuan GAO, Xianbo WANG. Risk factors for the 90-day prognosis of patients with type I hepatorenal syndrome and establishment of a predictive model[J]. Journal of Clinical Hepatology, 2022, 38(7): 1561-1565. doi: 10.3969/j.issn.1001-5256.2022.07.019
    [7]Perioperative Management Group, Chinese Society of Organ Transplantation, Chinese Medical Association. Expert consensus on perioperative vascular complications for liver transplantation(2021)[J]. Journal of Clinical Hepatology, 2021, 37(9): 2054-2057. doi: 10.3969/j.issn.1001-5256.2021.09.010
    [8]Bing GUO, Mingquan PANG, Xiaolei XU, Junwei HAN, Haijiu WANG. Establishment and evaluation of a nomogram for predicting post-hepatectomy complications in two types of hepatic echinococcosis[J]. Journal of Clinical Hepatology, 2021, 37(11): 2626-2631. doi: 10.3969/j.issn.1001-5256.2021.11.027
    [9]Yun ZHAO, Lijin ZHAO. Research advances in the risk factors for infection after liver transplantation[J]. Journal of Clinical Hepatology, 2021, 37(8): 1957-1962. doi: 10.3969/j.issn.1001-5256.2021.08.046
    [10]Mingwei LI, Jian GAO, Xiangwei ZHAI, Xiangjun QIAN, Xiajie WEN, Mingjie YAO, Zhaojun DUAN, Erjiang ZHAO, Ling ZHANG, Fengmin LU. Construction and analysis of a predictive model for posthepatectomy recurrence in patients with hepatocellular carcinoma based on preoperative CXCL13 measurement[J]. Journal of Clinical Hepatology, 2021, 37(4): 823-828. doi: 10.3969/j.issn.1001-5256.2021.04.020
    [11]Wang Han, Zuo XiangRong, Cao Quan. Predictive factors and interventions for prolonged mechanical ventilation after liver transplantation[J]. Journal of Clinical Hepatology, 2020, 36(7): 1658-1662. doi: 10.3969/j.issn.1001-5256.2020.07.047
    [12]Zhang DaLi, Feng DanNi, Zhang LiJuan, Tang RuJia, He Xi, Zhou Xia, Gao YinJie, Liu ZhenWen, Liu HongLing. Risk factors for recurrence after liver transplantation in patients with hepatocellular carcinoma and their prognosis[J]. Journal of Clinical Hepatology, 2020, 36(9): 1985-1989. doi: 10.3969/j.issn.1001-5256.2020.09.015
    [13]Zheng WeiPing, Shen ZhongYang. Risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma and related control strategies[J]. Journal of Clinical Hepatology, 2019, 35(11): 2391-2395. doi: 10.3969/j.issn.1001-5256.2019.11.003
    [14]Chen Long, Li Yue. The risk factors and prediction systems for posthepatectomy complications[J]. Journal of Clinical Hepatology, 2019, 35(1): 217-221. doi: 10.3969/j.issn.1001-5256.2019.01.048
    [15]Jie EnBo, Xuan FengHui, Sun XiaoDong, Sun DaWei, Lu: GuoYue. An analysis of risk factors for early complications after liver transplantation[J]. Journal of Clinical Hepatology, 2018, 34(6): 1282-1288. doi: 10.3969/j.issn.1001-5256.2018.06.030
    [16]Zhang YinTao, Meng JinYing, Guo ChunGuang, Wang Hua. Risk factors for biliary complications after common bile duct exploration combined with primary suture[J]. Journal of Clinical Hepatology, 2017, 33(2): 304-307. doi: 10.3969/j.issn.1001-5256.2017.02.021
    [17]Wang XinWei, Zhao ZongGang. Risk factors for infectious complications after hepatectomy in patients with intrahepatic bile duct stones[J]. Journal of Clinical Hepatology, 2017, 33(9): 1754-1757. doi: 10.3969/j.issn.1001-5256.2017.09.025
    [18]Wang MingYue, Lu ZhiYan. Imaging evaluation of complications after liver transplantation[J]. Journal of Clinical Hepatology, 2016, 32(12): 2295-2299. doi: 10.3969/j.issn.1001-5256.2016.12.013
    [19]Lu: GuoYue. Risk factors for biliary complications after liver transplantation from donation after cardiac death[J]. Journal of Clinical Hepatology, 2015, 31(12): 2027-2030. doi: 10.3969/j.issn.1001-5256.2015.12.009
    [20]Chen Man, Zhang Xia. Research advances in molecular prediction of recurrence and metastasis of primary liver cancer after liver transplantation[J]. Journal of Clinical Hepatology, 2014, 30(12): 1361-1365. doi: 10.3969/j.issn.1001-5256.2014.12.032
  • Cited by

    Periodical cited type(4)

    1. 李正优,李荷,周俊. 预见性护理结合舒适护理干预在肝移植术后患者中的应用. 西藏医药. 2024(06): 123-125 .
    2. 李珊珊,王媛,高春辉. 早期下床活动对肝移植术后患者胃肠功能及下肢血流的影响. 国际移植与血液净化杂志. 2023(01): 41-44 .
    3. 张欣悦,王海刚,王昊,杨传伟. 他克莫司治疗1例肝移植术后患者的药学监护. 中国医药导报. 2023(14): 183-187 .
    4. 种庚,彭晓春,吴若林,赵红川,邵敏. 成人肝移植术后早期严重并发症相关危险因素分析. 肝胆外科杂志. 2022(06): 454-459 .

    Other cited types(0)

  • 加载中
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 17.7 %FULLTEXT: 17.7 %META: 74.4 %META: 74.4 %PDF: 7.9 %PDF: 7.9 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 6.2 %其他: 6.2 %其他: 2.2 %其他: 2.2 %Absecon: 0.4 %Absecon: 0.4 %Caserta: 0.4 %Caserta: 0.4 %Seattle: 0.2 %Seattle: 0.2 %[]: 0.9 %[]: 0.9 %上海: 2.4 %上海: 2.4 %中央邦: 1.1 %中央邦: 1.1 %佛山: 0.2 %佛山: 0.2 %兰州: 0.4 %兰州: 0.4 %北京: 3.8 %北京: 3.8 %南京: 0.2 %南京: 0.2 %南宁: 0.4 %南宁: 0.4 %南昌: 2.4 %南昌: 2.4 %南阳: 0.2 %南阳: 0.2 %卡纳塔克: 0.2 %卡纳塔克: 0.2 %台州: 0.2 %台州: 0.2 %合肥: 0.2 %合肥: 0.2 %吉林: 0.7 %吉林: 0.7 %四平: 0.2 %四平: 0.2 %天津: 0.2 %天津: 0.2 %安庆: 0.2 %安庆: 0.2 %安康: 0.2 %安康: 0.2 %宣城: 0.4 %宣城: 0.4 %常德: 0.4 %常德: 0.4 %张家口: 4.2 %张家口: 4.2 %德罕: 0.2 %德罕: 0.2 %成都: 0.7 %成都: 0.7 %扬州: 0.2 %扬州: 0.2 %新乡: 0.2 %新乡: 0.2 %昆明: 2.2 %昆明: 2.2 %杭州: 0.5 %杭州: 0.5 %武汉: 0.5 %武汉: 0.5 %江门: 0.2 %江门: 0.2 %济南: 0.5 %济南: 0.5 %海得拉巴: 0.7 %海得拉巴: 0.7 %温州: 0.4 %温州: 0.4 %湘潭: 0.2 %湘潭: 0.2 %玉林: 0.4 %玉林: 0.4 %罗奥尔凯埃: 0.5 %罗奥尔凯埃: 0.5 %芒廷维尤: 36.2 %芒廷维尤: 36.2 %芝加哥: 0.2 %芝加哥: 0.2 %苏州: 0.2 %苏州: 0.2 %莆田: 0.2 %莆田: 0.2 %莫斯科: 2.0 %莫斯科: 2.0 %葫芦岛: 0.2 %葫芦岛: 0.2 %衡水: 0.4 %衡水: 0.4 %襄阳: 0.2 %襄阳: 0.2 %西宁: 14.6 %西宁: 14.6 %西安: 0.4 %西安: 0.4 %诺沃克: 1.8 %诺沃克: 1.8 %贵阳: 0.4 %贵阳: 0.4 %辽阳: 0.2 %辽阳: 0.2 %运城: 1.6 %运城: 1.6 %遂宁: 0.2 %遂宁: 0.2 %郑州: 0.2 %郑州: 0.2 %镇江: 0.4 %镇江: 0.4 %长春: 3.8 %长春: 3.8 %长沙: 0.5 %长沙: 0.5 %青岛: 0.2 %青岛: 0.2 %香港: 0.4 %香港: 0.4 %马尼拉: 0.2 %马尼拉: 0.2 %其他其他AbseconCasertaSeattle[]上海中央邦佛山兰州北京南京南宁南昌南阳卡纳塔克台州合肥吉林四平天津安庆安康宣城常德张家口德罕成都扬州新乡昆明杭州武汉江门济南海得拉巴温州湘潭玉林罗奥尔凯埃芒廷维尤芝加哥苏州莆田莫斯科葫芦岛衡水襄阳西宁西安诺沃克贵阳辽阳运城遂宁郑州镇江长春长沙青岛香港马尼拉

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1282) PDF downloads(279) Cited by(4)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return